At RECORNEA we’ve developed a groundbreaking intra-corneal implant to treat people with a progressive eye disease called keratoconus.
There are 218 M keratoconus eyes globally, a recurring market valued at $1B for 2 M new eyes every year.
We developed the GROSSO® corneal implant to both improve vision of the disease.
We raised 2 pre-seeds from Entrepreneur First in Singapore and GFACTOR in Italy plus a EU grant of 1.6 M€.